Articles On Telix Pharmaceuticals (ASX:TLX)

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and BERLIN, Germany, Nov. 13, 2024 /PRNewswire/ — Telix Phar...

It's been a rough session for the S&P/ASX 200 Index (ASX: XJO) and many ASX 200 shares so far this Tuesday. At the time of writing, the ASX 200 has retreated by a hefty 0.4% and is back under 8,240 points. But the broader market's fall...

Wellnex Life Ltd (ASX:WNX) has unveiled its plans to defer a $2.95M payment to 360 Health until it lists on the London exchange in January. Following its acquisition of topical pain relief product brand Pain Way, the cannabis-focused he...

Highlights ASX200 closed up, led by gains in IT and Utilities sectors. Leadership shake-up affects Mineral Resources, with major stock impact. Future Battery Minerals, Telix Pharmaceuticals see notable moves in the green.  The AS...

Highlights   ASX closed with a 0.56% gain, boosted by Utilities and IT sectors.   Notable gains for West Gold Resources Ltd and Telix Pharmaceuticals Ltd.   Small caps like Yandal Resources Ltd saw significant intra-day highs. The...

The ASX200 closed up 0.56% at 8164 points. In a tumultuous day on the market, Chris Ellison’s Mineral Resources shed 9.63% after it was dramatically revealed he will exit the business. The board ultimately lost confidence in him and says...

Highlights  ASX rises as banks drive gains amid strong Wall Street influence.  MinRes faces major drop following founder controversy. RBA decision and US rate outlook keep markets focused. The Australian stock market showed positi...

It was a very pleasant start to what is shaping up to be a big trading week for the S&P/ASX 200 Index (ASX: XJO) this Monday. After a sobering conclusion to last week's trading, investors seem...

  ASX closes higher despite Mineral Resources dip US dollar weakens amid uncertain election polling Ordell, Blue Star Helium star for small caps   The ASX closed Monday higher by 0.5%, riding the wave of optimism from Wall Street.  Howev...

The S&P/ASX 200 Index (ASX: XJO) is starting the week strongly. In afternoon trade, the benchmark index is up 0.5% to 8,161.7 points. Four ASX shares that are rising more than most today are listed below. Here's why they are climbing:...

Highlights    ASX gains slightly amid mixed performances in key sectors   Mineral Resources drops on leadership change, dragging mining sector   Energy sector declines despite oil price rally   The Australian share market experien...

Telix Pharmaceuticals will benefit from ongoing favourable US pay arrangements for high-value radiopharmaceutical diagnostics Optiscan teams with Monash University to develop a next-gen endomicroscope – and AI is involved BOD Australia inv...

Highlights  ASX rises, supported by tech and utilities sectors, despite mining and banking pressures. Mineral Resources dips amid management change; Westpac sees profit decline.  Select healthcare and property stocks show resilience...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are starting the week strongly. In morning trade, the ASX 200 healthcare stock is up 3% to $22.12. This leaves the radiopharmaceutical company's shares trading within a whisker of a new record hig...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Nov. 4, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (...

The S&P/ASX 200 Index (ASX: XJO) ended the trading week on a low note this Friday. After dropping for the past two trading days, the ASX 200 made it three for three today, falling 0....

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Oct. 30, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited...

The S&P/ASX 200 Index (ASX: XJO) endured a woeful Wednesday session today. After rising over the past two trading days, it was evidently time for investors to take a breather this hump...

At 11:40am, the S&P/ASX 200 is 0.24 per cent lower at 8,229.60. The SPI futures are pointing to a fall of 24 points. Best and worst performers The best-performing sector is Materials, up 0.88 per cent. The worst-performing sector is Con...

At 11:30am, the S&P/ASX 200 is 0.39 per cent higher at 8,253.30. The SPI futures are pointing to a rise of 27 points. Best and worst performers The best-performing sector is REITs, up 1.1 per cent. The worst-performing sector is Energy,...

The S&P/ASX 200 Index (ASX: XJO) enjoyed a bouncy but positive start to the week's trading this Monday. By the time the markets wrapped up, the ASX 200 had advanced by 0.12% and finishe...

Get our share tips straight to your inbox – Sign Up Here John Edwards, Novus Capital   BUY RECOMMENDATIONS   BUY – Telix Pharmaceuticals (TLX)   Telix is developing a portfolio of clinical stage products that aim to address unmet medical ne...

The ASX200 closed down 0.12% at 8,206 points. In breaking news, the founder of Wisetech Richard White will stand down as CEO and director of the company. The move comes in the wake of numerous allegations of inappropriate conduct. Tel...

The S&P/ASX 200 Index (ASX: XJO) had a wild, but ultimately unsuccessful, Thursday session today. After a bouncy week, the ASX 200 notched up another retreat this session, dropping by an a...

ASX ends very modestly lower after a mixed session Newmont and Fortescue shares drop on disappointing updates WiseTech continues its slide as investors start to grumble   Aussie shares swung to a flattish close today after earlier losses...

The S&P/ASX 200 Index (ASX: XJO) is fighting hard to stay in positive territory. In afternoon trade, the benchmark index is up 0.1% to 8,223.7 points. Four ASX shares that are rising more than most today are listed below. Here's why t...

Telix Pharmaceuticals’ brain cancer diagnostic could leapfrog over its kidney cancer assay to be its second commercialised product Rhythm Biosciences still hopes to flush the bowel cancer ‘poo test’ into history Today’s quarterly reports s...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are rising on Thursday morning. In morning trade, the ASX 200 healthcare stock is up 2% to $21.54 Why is this ASX 200 healthcare stock rising? Investors have been bidding the radiopharmac...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Oct. 24, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Oct. 22, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin An additional news report on the recommendation, valuation, forecast and opinion cha...

Not every S&P/ASX 200 Index (ASX: XJO) stock is going to shoot the lights out and deliver 10-bagger plus returns in just five years. Indeed, some will invariably head in the other direction and erode the value of your initial invest...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin SPI futures on the S&P/ASX 200 are up 0.5%, inching the benchmark back up toward...

The S&P/ASX 200 Index (ASX: XJO) endured a fairly miserable end to the trading week this Friday, with investors pulling back from the new record highs we saw yesterday. By the time trading wra...

Highlights ASX falls as weak Chinese economic data hits commodity stocks. Gold miners rally while most sectors experience losses. Major banks post mixed results amidst broader market decline. Australian stocks extended their losse...

A top ASX stock is heading off to try its fortunes on the Nasdaq Composite Index (NASDAQ: .IXIC). Don't worry, though. If its Nasdaq listing plans proceed as planned, the S&P/ASX 100 Index (ASX: XTO) company will be dual-listed, me...

Telix Pharmaceuticals (ASX:TLX) reveals its quarterly revenues while also reaffirming its full-year 2024 revenue guidance. In a statement, the company said that for the quarter revenue totaled AU$201, primarily generated from sales of i...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Oct. 17, 2024 /PRNewswire/ – Telix Pharmaceuticals Limited...

  ASX closes  higher led by Wall Street gains ReNu Energy reveals partial offer for hydrogen assets Web Travel plunges 30pc amid declining margins   The ASX closed 0.47% higher on Monday, buoyed by strong Wall Street leads, with the S&am...

Cancer drug developer Chimeric Therapeutics eyes minimum $5 million raising ‘The next Telix’, Clarity gets FDA go-ahead for prostate cancer trial LTR Pharma fleshes out erectile dysfunction trial results   Cancer cell therapy house Chimer...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Oct. 8, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (...

Big biotech names support Island Therapeutics raising Radiopharm eyes FDA approval to start a therapeutic pan-cancer trial Truscreen’s cervical cancer diagnostic cracks a nice mention   Health Check is renowned biotech journo Tim Boreham’...

Biome Australia believes it can almost quadruple its probiotics revenue over next three years  Anteris faces delay to proposed Nasdaq listing and IPO Artrya asks FDA to approve its AI-based heart plaque detection algo Stalemate: Pacific Sm...

The S&P/ASX 200 Index (ASX: XJO) has been on form this year and has recorded a solid gain. Since the start of the year, the benchmark index has risen 8.2%. And this doesn't include the dividends that have been paid during the period....

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

ASX healthcare sector shows signs of recovery after latest earnings season Pathology and aged care face ongoing staffing and cost challenges Jarden highlights Telix Pharma and CSL as key investment picks   Key themes of FY24 reporting sea...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 8196.00 – 9.00 – 0.11% S&P ASX 200 8152.90 –...

The Australian sharemarket experienced a decline from record highs, primarily due to investor concerns regarding the Reserve Bank's potential delay in interest rate cuts, expected to remain steady at 4.35 per cent for the seventh consecutiv...

Melbourne-based biotech Telix Pharmaceuticals (ASX: TLX) has expanded its North American manufacturing base through the acquisition of RLS (USA) Inc for up to US$250 million ($366.5 million). The deal gives Telix access to 31 licensed radi...

Telix Pharmaceuticals Limited (ASX: TLX), a prominent oncology company specializing in radiopharmaceuticals, has announced its acquisition of RLS (USA), Inc. for $338 million (USD 230 million). This strategic move significantly expands Teli...